Evidence map›Paper›PMID 20491730›Full record

ArticleAddiction (Abingdon, England)2010

Individuals receiving addiction treatment: are medical costs of their family members reduced?

Constance Weisner, Sujaya Parthasarathy, Charles Moore, Jennifer R Mertens

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Predicting Hazardous Alcohol Drinking Behaviors in Family Members of Hazardous Alcohol-Drinker Patients.International journal of environmental research and public health · 2022
    Article
  10. State of the Art in Substance Use Prevention and Early Intervention: Applications to Pediatric Primary Care Settings.Prevention science : the official journal of the Society for Prevention Research · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Al-Anon newcomers: benefits of continuing attendance for six months.The American journal of drug and alcohol abuse · 2016
    Article
  19. Family substance use screening: less to hide, more to gain.The Indian journal of medical research · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Constance WeisnerDepartment of Psychiatry, University of California, San Francisco, CA, USA. constance.weisner@kp.org
Sujaya Parthasarathy
Charles Moore
Jennifer R Mertens

Funding

Family Members of Alcohol Patients: Utilization and CostR01AA015183 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISNER, CONSTANCE M. · 2004 to 2014
$1.6M
NIAAA NIH HHS R01 AA015183NIAAA NIH HHS R01 AA115183
6 · The paper itself

Abstract

aimsTo examine whether alcohol and other drug (AOD) treatment is related to reduced medical costs of family members.

designUsing the administrative databases of a private, integrated health plan, we matched AOD treatment patients with health plan members without AOD disorders on age, gender and utilization, identifying family members of each group.

settingKaiser Permanente Northern California.

participantsFamily members of abstinent and non-abstinent AOD treatment patients and control family members. MEASUREMENTS: We measured abstinence at 1 year post-intake and examined health care costs per member-month of family members of AOD patients and of controls through 5 years. We used generalized estimating equation methods to examine differences in average medical cost per member-month for each year, between family members of abstinent and non-abstinent AOD patients and controls. We used multilevel models to examine 4-year cost trajectories, controlling for pre-intake cost, age, gender and family size.

resultsAOD patients' family members had significantly higher costs and more psychiatric and medical conditions than controls in the pre-treatment year. At 2-5 years, each year family members of AOD patients abstinent at 1 year had similar average per member-month medical costs to controls (e.g. difference at year 5 = $2.63; P > 0.82), whereas costs for family members of non-abstinent patients were higher (e.g. difference at year 5 = $35.59; P = 0.06). Family members of AOD patients not abstinent at 1 year, had a trajectory of increasing medical cost (slope = $10.32; P = 0.03) relative to controls.

conclusionsSuccessful AOD treatment is related to medical cost reductions for family members, which may be considered a proxy for their improved health.

Indexed as

Family HealthAdultCaliforniaCase-Control StudiesChildChronic DiseaseDelivery of Health Care, IntegratedFamilyFemaleHealth Care CostsHealth ServicesHealth StatusHumansMaleModels, StatisticalSubstance-Related Disorders

Identifiers

PMID20491730
PMCPMC2907442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.